Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Depreciation & Amortization (CF) (2024 - 2025)

Updated

Niki BioSolutions (NIKI) posted Depreciation & Amortization (CF) of $9,772 for FY2025.

Analysis

Niki BioSolutions (NIKI) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

Since FY2017, Niki BioSolutions has reported Depreciation & Amortization (CF) for 9 years.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -62.6% (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Depreciation & Amortization (CF) in data going back to FY2017.
  • Business Quant data shows NIKI's Depreciation & Amortization (CF) at $255,046 in FY2024 (-77.3%), $1.13 million in FY2023 (-6.8%), $1.21 million in FY2022 (+1.3%) and $1.19 million in FY2021 (-10.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Niki BioSolutions 2.65 Mn 2.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 4,921.00
Nov 30, 2024 4,976.00
Aug 31, 2024 5,179.00
API Access

Niki BioSolutions Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NIKI&period=max&api_key=YOUR_API_KEY